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LENGTHENING THE STEM: ALLOWING FEDERALLY
FUNDED RESEARCHERS TO DERIVE HUMAN
PLURIPOTENT STEM CELLS FROM EMBRYOS
Jason H. Casell*
Recent developments in fetal tissue research and stem cell research have led to
dramatic breakthroughs in the search for cures for Parkinson's disease, Alz-
heimer's disease, diabetes, and a host of neurological disorders. Because this
research involves fetal tissue and stem cells from human embryos, many compli-
cated ethical and legal implications surround it. This Note explores the history of
fetal tissue research and stem cell research, examines the surrounding ethical and
legal issues, looks at the current state of federal law, and concludes that Congress
should allow federally funded researchers to derive stem cells from discarded
human embryos obtained from in vitro fertilization clinics.
Fetal tissue research and stem cell research both hold enormous
promise for victims of Parkinson's disease, Alzheimer's disease,
other neurological disorders, and diabetes. New treatments and,
ultimately, cures may be on the horizon. Stem cell research in par-
ticular has the potential to affect virtually every realm of medicine
in a dramatic way. It is critical that this research be supported and
broadened.
This Note argues that Congress should grant federal funding for
the derivation of stem cells from human embryos. The law
currently allows research on stem cells derived from discarded
human embryos as long as the procedures through which the stem
cells are removed from the embryos are not federally funded. Part
I of this Note examines the history and development of (ex-utero)
fetal tissue research and stem cell research. Part II discusses the
ethical and legal issues surrounding this research. Part III
examines the current state of federal law on fetal tissue research
and stem cell research. Finally, the Note concludes that expanding
federal legislation and National Institutes of Health (NIH)
guidelines through the passage of the Stem Cell Research Act of
2001 will allow federally funded researchers to derive stem cells
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from discarded embryos obtained from in vitro fertilization (LVF)
clinics, potentially accelerating advances in the study of diseases
and expediting the development of new treatments.
I. HISTORY AND DEVELOPMENT OF FETAL
TISSUE RESEARCH AND STEM CELL RESEARCH
A. Fetal Tissue Research
Extensive use of fetal tissue for medical research in the United
States began in the 1950s when Dr. Jonas Salk used human fetal
kidney cells to develop the polio vaccine.' Researchers soon trans-
planted fetal thymus glands2 into children with thymus deficiencies
in order to allow recipients' immune rejection systems to operate
normally.3 Scientists believe fetal tissue research could hold count
less benefits for millions suffering from a host of neurologicalS 4 • 5
diseases, particularly Parkinson's disease.
Fetal tissue is preferred to adult tissue because fetal cells main-
tain their plasticity, 6 change shape to place themselves in the
correct location, are able to integrate and grow in new surround-
ings, and are less immunogenic than adult cells, making rejection
1. Daniel E. Koshland, Jr., Editorial, Fetal Tissue Research, 256 Sci. 1741, 1741 (1992)
(describing the benefits of fetal tissue research).
2. During fetal development, the thymus gland processes many of the body's lym-
phocytes, which travel through the bloodstream seeding lymph nodes and lymphatic tissue.
Encyclopedia.com, Thymus Gland, at http://www.encyclopedia.com/printable/12858.html
(last visited Feb. 13, 2001) (on file with the University of Michigan Journal of Law Reform). A
heterogeneous group of cells, known as T-cells, undergoes this process, which is essential in
establishing the body's immune system. Id.
3. RuSSELL ScoTT, THE BODY AS PROPERTY 37 (1981) (describing uses of fetal tissue
research).
4. Gina Kolata, FederalAgency Bars Implanting of Fetal Tissue, N.Y. TIMES, Apr. 16, 1988,
atFI (discussing the potential use of fetal tissue for treating certain incurable diseases).
5. Parkinson's disease is a slowly progressive degenerative disease affecting a small
area of cells in the middle part of the brain. Nat'l Parkinson Foundation, What the Patient
Should Know, at http://www.parkinson.org/pdedu.htm (last visited Feb. 26, 2001) (on file
with the University of Michigan Journal of Law Reform) (providing an overview of Parkinson's
disease). The degeneration of these cells can produce one or more of the typical signs of
Parkinson's disease, including tremors, slow movement, stiff limbs, balance problems, and
depression. Id. Parkinson's disease affects approximately 1.5 million Americans, fifteen
percent of whom are diagnosed before age fifty; one of every 100 people over sixty years old
is affected by the disease. Id.
6. Plasticity is the ability of tissue to undergo differentiation, which allows it to renew




less likely.7 Additionally, the supply of fetal tissue is far more abun-
dant than the supply of tissue voluntarily donated by adults.8
In the wake of the United States Supreme Court's decision in
Roe v. Wad, federal regulations mandated that fetal tissue used in
research be obtained from either miscarried fetuses or fetuses
aborted due to ectopic pregnancies in which the fetus implants in
the fallopian tube instead of the uterus and cannot be carried to
term.'0 Scientists, however, prefer first-trimester fetuses aborted
through elective procedures because tissue obtained through mis-
carriages and ectopic pregnancies usually has pathological flaws."
Tissue from an otherwise healthy, electively aborted fetus is useful
for a multitude of research and transplantation purposes, whereas
the usefulness of tissue obtained from miscarriages and ectopic
pregnancies is limited. Because it originates from a fetus that was,
for some pathological reason, rejected by a pregnant woman's
body, such tissue will not prove helpful in the search for treat-
ments and cures for diseases and conditions unrelated to
pregnancy.
In a study conducted at the University of Colorado at Denver,
forty patients with advanced Parkinson's disease received surgical
implants of fetal dopaminergic cells 12 or underwent a sham surgical
procedure. Positron emission tomography (PET) 4 demonstrated
7. See id.
8. In 1997, the most recent year for which data is available, there were 1,186,039 le-
gally induced abortions in the United States reported to the Centers for Disease Control
and Prevention. Centers for Disease Control and Prevention, Abortion Surveillance-United
States, 1997, at http://www.cdc.gov/mmwr/preview/mmwrhtml/ss491 al.html (last visited
Dec. 1, 2000) (on file with the University of Michigan Journal of Law Reform) (listing abortion
statistics). According to the United Network for Organ Sharing, which compiles national
tissue and organ transplant data, there were 10,576 cadaveric and living donors in 1999.
United Network for Organ Sharing, Critical Data, Facts About Transplantation, at
http://www.unos.org/Newsroom/critdatamain.htm (last visited Apr. 5, 2001) (on file with
the University of Michigan Journal of Law Reform). More than 75,000 patients are currently
waiting for transplants. Id.
9. 410 U.S. 113 (1973).
10. See discussion infra Part III.A.
11. Kathy A. Fackelmann, Study Sizes Up Fetal Cells for Transplant, 147 Sci. NEWS 6, 6
(1995).
12. Dopamine is a chemical in the brain that plays a crucial role in movement and
cognition. The degeneration of dopamine produces the symptoms of Parkinson's disease.
Fetal dopaminergic cells replace the lost dopamine in Parkinson's patients. PHILIP G.
STRANGE, BRAIN BIOCHEMISTRY AND BRAIN DISORDERS 163-71 (1992).
13. Larry Husten, Fetal-Cell-Implantation Trial Yields Mixed Results, 353 LANCET 1501,
1501 (1999) (discussing the first reported randomized, placebo-controlled trial of implanta-
tion of fetal cells to stimulate dopamine activity in patients with Parkinson's disease).
14. This technology monitors biochemical changes within the body by detecting and
modeling concentrations of radioactivity in particular regions of the body. See Dep't of Bio-
logical & Agricultural Eng'g, North Carolina State Univ., Functions of PET, at
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that dopamine activity increased more than twenty percent in
more than half of the patients in the group receiving implants,
compared with zero percent of the placebo group patients."5 More
than half of the patients under sixty years old who received im-
plants experienced significant improvements in movement.1
6
These patients were younger with greater brain plasticity (their
brains were able to repair injured tissue more easily), which may
account for the more marked improvement in their movement.
1 7
Another degenerative brain disorder, Huntington's disease, has
attracted the attention of researchers in France. 8 Clinical trials are
underway to treat the disease using fetal tissue.' 9 Five patients with
Huntington's disease had fetal cells that had already begun differ-
entiating into nerve tissue implanted into the parts of their brains
controlling movement.20 Three of the five patients demonstrated
improved movement and cognitive function.' The promising re-
sults of clinical trials such as these likely will lead to more studies of
this kind.
http://www.bae.ncsu.edu/bae/courses/bae590f/1995/mullen/functions.html (last visited
Mar. 15, 2001) (on file with the University of Michigan Journal of Law Reform).
15. Husten, supra note 13, at 1501.
16. Id.
17. Id. It was recently reported that symptoms intensified due to fetal cell growth in
about fifteen percent of the patients receiving fetal cell implants. Curt R. Freed et al.,
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease, 344 NEW ENG. J.
MED. 710, 716, 718 (2001); Gina Kolata, Parkinson's Research Is Set Back by Failure of Fetal Cell
Implants, N.Y. TIMES, Mar. 8, 2001, at Al. Hours after the findings of the study were released,
Nightlight Christian Adoptions, a pro-life organization, filed a lawsuit demanding that the
NIH stop funding research with stem cells derived from human embryos. Dawn MacKeen,
Controversial Cell Research Takes a Hi, SALON.COM, Mar. 9, 2001, at http://www.salon.com/
mwt/feature/2001/03/09/stem cells/index.html (on file with the University of Michigan
Journal of Law Reform). Although opponents of fetal tissue research and stem cell research
may be buoyed by the results of the Parkinson's study, these results only point to the need
for further research and studies. See Editorial, A Setback in Parkinson's Research, N.Y. TIMES,
Mar. 9, 2001, at A20.
18. Huntington's disease, which affects more than 250,000 Americans, is a hereditary,
degenerative brain disorder for which there is no known effective treatment or cure. Hunt-
ington's Disease Soc'y of Am., What is Huntington's Disease ?, at http://www.hdsa.org/about/
about.pl?whatishd (last visited Mar. 15, 2001) (on file with the University of Michigan Journal
of Law Reform). Each child of a person with the disease, which crosses all racial, ethnic, and
gender barriers, has a fifty percent chance of inheriting it. Id. Anyone who carries the gene
will develop the disease, and many people at risk choose to avoid taking a test to determine
if they are carriers. Id. Early symptoms of the disease, which usually strikes victims between
the ages of thirty and forty-five, include forgetfulness, involuntary twitching, and lack of
coordination. Id. As the disease progresses, victims lose the ability to walk, speak, and swal-
low, eventually deteriorating to the point where they are unable to care for themselves. Id.
Death often results from choking, infection, or heart failure. Id.
19. Jonathan Knight et al., Reach for the Prize, NEW SCIENTIST, Nov. 18, 2000, at 10, 11
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B. Stem Cell Research
Stem cell research holds even more promise than fetal tissue re-
search for treating virtually all diseases. Even though they cannot
become an entire human being, human pluripotent stem cells
(HPSCs) have the ability to divide from human embryos and give
rise to most of the specialized cells and tissues of the body.23 HPSCs
are derived from embryos created for the purposes of fertility
treatment and in excess of clinical need. 4 HPSCs are removed
from the embryo after the sperm has fertilized the egg at the bias-25 26
tocyst stage," the point at which embryos are frozen in storage.
HPSCs have unique abilities to renew themselves and form
many different cell types, even complex tissues. On the other
hand, scientific evidence suggests that the full potential of adult
stem cells is more limited. 2s Adult stem cells may be able to divide
22. In 1998, David Thomson, a researcher at the University of Wisconsin at Madison,
isolated human pluripotent stem cells (HPSCs) from human embryos that were a few days
old. After four to five months of undifferentiated proliferation, these cells maintained the
potential to form derivatives of embryonic germ layers, cartilage, bone, muscle, and neural
parts. James A. Thomson et al., Embryonic Stem Cell Lines Derived from Human Blastocysts, 282
Sci. 1145, 1145-46 (1998).
23. NIH Fact Sheet on Human Pluripotent Stem Cell Research Guidelines, at http://
www.nih.gov/news/stemcell/stemfactsheet.htm (last visited Mar. 15, 2001) (on file with the
University of Michigan Journal of Law Reform) (discussing HPSCs and contrasting them with
human totipotent stem cells, which do have the potential to become entire human beings).
24. Nat'l Insts. of Health, National Institutes of Health Guidelines for Research Using Hu-
man Pluripotent Stem Cells, at http://www.nih.gov/news/stemcell/stemcellguidelines.htm
(last visited Mar. 15, 2001) [hereinafter Guidelines on Pluripotent Stem Cells] (on file with the
University of Michigan Journal of Law Reform).
25. Gabriel S. Gross, Comment, Federally Funding Human Embryonic Stem Cell Research:
An Administrative Analysis, 2000 Wis. L. REV. 855, 856-57.
26. John A. Robertson, In the Beginning: The Legal Status of Early Embryos, 76 VA. L. REv.
437, 440 (1990).
27. The stem cells of a particular tissue are defined as "(a) undifferentiated cells (i.e.
lacking certain tissue specific differentiation markers), (b) capable of proliferation, (c) able
to self-maintain the population, (d) able to produce a large number of differentiated, func-
tional progeny, (e) able to regenerate the tissue after injury, and (f) flexible use of these
options." Markus Loeffler & Christopher S. Potten, Stem Cells and Cellular Pedigrees-A Con-
ceptual Introduction, in STEM CELLS 1, 5 (C.S. Poten ed., 1997).
28. Nat'l Insts. of Health, NIH Statement Before the Senate Appropriations Subcommittee, at
http://www.nih.gov/news/stemcell/State.htm (reprinting the statement of Dr. Allen M.
Spiegel, Director of the National Institute of Diabetes and Digestive and Kidney Diseases,
and Dr. Gerald D. Fischbach, Director of the National Institute of Neurological Disorders
and Stroke) (last visited Oct. 14, 2000) [hereinafter NIH Statement] (on file with the Univer-
sity of Michigan Journal of Law Reform). In three separate experiments, stem cells from bone
marrow repaired damaged heart tissue in animals. Nicholas Wade, Stem Cells Yield Promising
Results, N.Y. TIMES, Mar. 30, 2001, at Al. In one of these experiments, Dr. Piero Anversa of
New York Medical College and Dr. Donald Orlic of the NIH injected primitive stem cells
from a donor mouse's bone marrow into mice in which heart attacks had been induced and
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only a limited number of times, which reduces their utility in pro-
ducing adequate numbers of well-characterized cells for
therapies.9 Adult stem cells also may be less robust than HPSCs,
making them more susceptible to disease once transplanted into
the body.3°
HPSCs could be used to generate cells and tissues for cell trans-
plantation therapies resulting from the dysfunction of specific cells
and tissues and to create a renewable supply of cells, tissues, and
organs. 3' Because the demand for cells, tissues, and organs for
transplantation far exceeds the supply, HPSCs could save the lives
of thousands of people who would otherwise die while waiting for
transplants.
3 2
Furthermore, HPSCs show great promise in curing type I diabe-
tes, or juvenile diabetes, which is characterized by the body's
inability to produce insulin, a hormone necessary for glucose me-. 33
tabolism. HPSCs have the potential to provide a limitless supply
of islet cells, the cells needed for transplantation in type I diabetes
34patients. Due to the shortage of islet cells, only about five percent
of those with diabetes who have received islet cell transplants have
been able to stay off insulin for more than a year.35 Utilizing HPSCs
to generate a vast source of islet cells could dramatically increase
the currently low success rate of islet cell transplants.
3 6
found that the stem cells generated new heart tissue. This was the first time that new heart
tissue had been generated from injected cells. Donald Orlic et al., Bone Marrow Cells Regener-
ate Infarcted Myocardium, 410 NATURE 701, 701-05 (2001). Clinical trials in humans are at
least a year away, see Wade supra, and, although this use of adult stem cells looks promising,
it does not obviate the need for continued research using HPSCs. See Nicholas Wade, Find-
ings Deepen Debate on UsingEmbryonic Cells, N.Y. TIMES, Apr. 3, 2001, at D1. Another new study
shows that human fat may be a potentially rich source of adult stem cells. See Michael D.
Lemonick, Who Will Live Longest ?, TIME, Apr. 23, 2001, at 64. Researchers at the University of
California at Los Angeles and the University of Pittsburgh obtained stem cells from liposuc-
tioned human fat and made them grow into bone, muscle, and cartilage cells. Id. Before
human clinical trials occur, however, scientists must make sure that the stem cells do not
form tumors or revert to their original form-turning bone to fat. Emily Sohn, Therapy by the
Pound, U.S. NEWS & WORLD RP., Apr. 23, 2001, at 54.





34. Id. Islet cells, or islets of Langerhans, are groups of specialized cells in the pancreas
that produce insulin and make and secrete hormones. See MedicineNet.com, Islets of Langer-
hans, at http://www.medicinenet.com/Script/Main/Art.asp?li=MNI&AricleKey-4054 (last
visitedJan. 28, 2001) (on file with the University of Michigan Journal of Law Reform).
35. NIH Statement, supra note 28.
36. Id; see also CNN.com, Subcommittee Hears Testimony on Stem Cell Research, at http://
www.cnn.com/2000/Health/09/14/stemcell.hearing.02/index.html (last visited Oct. 14,
2000) (on file with the University of Michigan Journal of Law Reform) (recounting congres-
[VOL. 34:3
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In a recent breakthrough, NIH scientists used the embryonic
stem cells of mice to generate cells expressing insulin and other
pancreatic endocrine hormones in mice with type I diabetes. 7 The
cells self-assembled to form three-dimensional clusters similar to
normal pancreatic islets where pancreatic cell types are closely as-
sociated with neurons. Glucose triggered insulin release from
these cell clusters, and when injected into mice, the insulin-
producing cells maintained a clustered, islet-like organization,
enabling the mice to live longer. 9 One of the researchers on this
project has now moved to a private laboratory to replicate her
work with HPSCs. "°
Animal pluripotent stem cells (PSCs) also are being used by bi-
ologists at Rockefeller University in the therapeutic cloning of
mice.4 ' Researchers converted the skin cells of mice tails into em-
bryonic stem cells, and colleagues at the Memorial Sloan Kettering
Cancer Center then morphed those cells into the dopamine-
producing cells of the brain lost in Parkinson's disease. 2 Research-
ers have not yet injected the dopamine-producing cells into the
brains of mice with Parkinson's disease to see if the disease's symp-
toms are alleviated. 3
Scientists atJohns Hopkins University are using rat PSCs to treat
the animal equivalent of motor neuron disease, which paralyzes
humans.44 In laboratory experiments, rats injected with PSCs in
their spinal fluid regained partial leg movement.4 5 Actor and
director Christopher Reeve, paralyzed from the neck down in an
equestrian accident, continues to campaign for human clinical tri-
46als of this type.
sional testimony from actress Mary Tyler Moore, who has suffered from diabetes for over
thirty years, discussing stem cell research in Canada where healthy pancreatic cells were
transplanted into young diabetics, many of whom no longer need insulin injections).
37. Gretchen Vogel, Stem Cells Are Coaxed to Produce Insulin, 292 Sc. 615, 615-17
(2001).
38. Id. at 617.
39. Id.
40. Nicholas Wade, Scientists Report 2 Major Advances in Stem-Cell Work, N.Y. TIMES, Apr.
27, 2001, at Al.
41. Teruhiko Wakayama et al., Differentiation of Embryonic Stein Cell Lines Generated from
Adult Somatic Cells by Nuclear Transfer, 292 Sc. 740, 740-42 (2001).
42. Id.
43. Wade, supra note 40, at Al.
44. Knight et al., supra note 19, at 11.
45. Id.
46. Id. at 10.
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II. ETHICAL AND LEGAL ISSUES SURROUNDING RESEARCH
A. Evolving Concerns in Fetal Tissue Research
When abortion was legalized in 1973, widespread concern arose
in Congress that the use of fetal tissue for transplantation might
encourage pregnant women to have abortions in order to donate
their fetuses for research.47 Some women have believed that they
could donate tissue to help a relative suffering from a malady such
as Parkinson's disease,48 but there is no documented instance of a
woman having an abortion in order to donate fetal tissue. Several
factors likely account for this. Abortion is a difficult decision for
any woman to make, and it seems unlikely a woman would become
pregnant intending to abort the fetus even if the purpose was to
help a loved one. Also, because of the antigenetic nature of fetal
tissue cells, there is a lower risk of rejection by the immune sys-
tem. 49 As a result, there is much less concern with finding a
compatible donor.
The concern about women aborting fetuses for research seemed
to be displaced by the fear that a black market would develop in
the selling of fetal tissue. The television newsmagazine 20/20 re-
cently conducted a hidden camera investigation finding "evidence
that some businessmen are trafficking in fetuses." 0 Journalist Chris
Wallace interviewed Dr. Miles Jones, the owner and operator of
Opening Lines, a tissue company that sells fetal parts obtained
from abortion clinics to research facilities. 5' Although the law al-
lows tissue companies to recover their costs, they are not permitted
to profit from the sale of human parts,52 but Opening Lines dis-
tributed a price list charging $325 for a spinal cord, $550 for a
reproductive organ, and $999 for a brain.53 In the following hidden
47. Alan Fine, The Ethics of Fetal Tissue Transplants, HASTINGS CENTER REP., June-July
1988, at 5, 6.
48. Marlene Cimons, Fetal Tissue Research Stirs Debate, L.A. TIMES, Sept. 26, 1988, at B3
(discussing a wife's desire to help her ailing husband).
49. See Kolata, supra note 4, at F1.
50. 20/20: Parts for Sale (ABC television broadcast, Mar. 8, 2000) [hereinafter Parts for
Sale] (describing an alleged underground market for fetal parts); see also Kevin Murphy,
Fetal Tissue Research Complex and Divisive, KAN. CITY STAR, Apr. 1, 2000, at Al (discussing the
FBI's investigation into whether fetal parts were illegally sold by independent companies
working at a clinic in Overland Park, Kansas).
51. Parts for Sale, supra note 50.
52. 42 U.S.C. § 289(g) (2) (2000) ("It shall be unlawful for any person to knowingly
acquire, receive, or otherwise transfer any human fetal tissue for valuable consideration if
the transfer affects interstate commerce.").
53. Parts for Sale, supra note 50 (discussing price list).
[VOL. 34:3
Lengthening the Stem
camera exchange, a 20/20 producer posing as a prospective in'es-
tor met with Dr. Jones:
PRODUCER: What does a brain go for? What does a kidney
or liver go for?
JONES: It's market force. It's what can you sell it for? .... We
had projections of $50,000 a week. And you know, some
weeks you can hit that and some weeks you can't. It's just a
matter of being able to match supply and demand.... That
one fetus-[for which Jones said he pays $50 and charges an
average of $250] the cost of procuring it is the same whether
you get one kidney or you get two kidneys, a lung, a brain, a
heart. It's the same cost that you've put into it.... Each re-
searcher gets charged.
PRODUCER: And each time that's just money in the bank?
JONES: Mm-hmm.54
This broadcast report led Congress to subpoena Jones to testify
in its hearings on fetal tissue research in which Dean Alberty, a
whistleblower from inside Jones' company, testified . Alberty took
$10,000 from a pro-life group to gather information, a fact in-
cluded in the broadcast,56 but he did admit to lying to the group
about some of what he witnessed even though he contends his
congressional testimony is true. Jones was held in contempt of
Congress for failing to testify, 58 and the entire matter was referred
to the United States Department of Justice and the Federal Bureau
of Investigation.
Similar black market dangers may exist for embryos and stem
cells.6° Opponents of federal funding for stem cell research fail to




57. Fetal Tissue Hearing: FBI Will Investigate Sales, AM. POL. HEALTH NETWORK HEALTH
LINE, Mar. 13, 2000, at 6 (summarizing Alberty's testimony).
58. H.R. RF.p. No. 106-527, at 4-5 (2000).
59. Letter from United States House of Representatives Committee on Commerce
Democrats, to Janet Reno, Attorney General, United States Department of Justice, and
Louis Freeh, Director, Federal Bureau of Investigation (Mar. 9, 2000), at http://
www.house.gov/commerce-democrats/press/1061trlOO.htm (last visited May 7, 2001) (on
file with the University of Michigan Journal of Law Reform).
60. See Antonio Regalado, Private Studies of Emb7yo Cells Raise Concerns, WALL ST. J., Mar.
21, 2001, at BI (discussing the growth of private efforts to conduct research with HPSCs).
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and ethical oversight accompanying federal funding and that such
an unregulated research industry may foster an underground mar-
ket in stem cells.6' A black market could be prevented, however, by
awarding federally funded researchers greater autonomy. Allowing
62these researchers to derive their own stem cells or clone embryos
would reduce the incentive for black markets while allowing the
researchers to have greater control over their work.
B. Special Nature of the Embryo
Ethical concerns involving stem cell research derive from what
bioethicists often speak of as the moral or special nature of the
embryo.6 The embryo has qualities of a living being and a human
being, but it is not a human life because it lacks neurological at-
tributes that we ascribe to humans in the special sense. 4 An
embryo is biologically alive in a general sense, but it does not have
cerebral functions that give rise to consciousness.
65
Cryopreservation, the freezing and storing of human embryos,
further complicates the classification of the embryo. Scientist Lee
Silver constructs a way of examining frozen embryos, the source
for HPSC research, by asking whether the frozen embryo is alive.
6
The frozen embryo with all its molecules at a standstill exists in a
state of suspended animation.67 In this sense, the frozen embryo is
indistinct from an inanimate object and is not alive.6 Yet, the fro-
zen embryo also retains the structure and genetic information of a
living organism for an indefinite period, making it alive in this
sense.66 Finally, Silver asks if the frozen embryo has the potential to
61. Id. (relaying the remarks of Daniel Perry, Director of the Alliance for Aging Re-
search, a research advocacy group: "The irony is that those who have opposed federal
funding claiming a moral posture seem quite unconcerned that there will be demand and
supply of embryonic cells and fetal tissue, and that without government involvement it
would be quite unguarded."). Only one company, the WiCell Institute, sells stem cells in the
United States. Id. The stem cells provided by WiCell do not comply with the NIH's pro-
posed ethical. guidelines. These guidelines discourage the creation of embryos solely for
research and require detailed consent from couples who choose to donate spare embryos
from IVF procedures. Id.
62. See infra notes 182-84 and accompanying text.
63. See generally LEE SILVER, REMAKING EDEN: CLONING AND BEYOND IN A BRAVE NEW
WORLD 40-47 (1997) (describing attributes of the embryo).
64. Id. at 41.
65. Id. at 22.
66. Id. at 79.
67. Id.
68. Id.
69. Id. at 79-80.
[VOL. 34:3
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become reanimated. This question has no definitive answer since
procedures for cryopreservation yield completely living embryos,
completely dead embryos, and embryos combining living and dead
cells.7° Therefore, the frozen embryo is neither alive nor dead, but
rather in a completely different state altogether. 7' The following
examples illustrate the complications arising from the special na-
ture of the frozen embryo.
1. Orphaned Embryos-In 1981, Mario and Elsa Rios, a California
couple who had been struggling for years to conceive a child, vis-
ited an IVF clinic in Melbourne, Australia. 72 At that time, few IVF
clinics existed in the United States, and, at thirty-seven, Elsa was
deemed too old for treatment.73 At the clinic, doctors discovered
Mario was infertile, so the couple agreed to have three of Elsa's
eggs fertilized with sperm from an anonymous donor.4 One of the
three embryos was implanted in Elsa's uterus, and the remaining
two embryos were frozen.75 Elsa miscarried soon after the implan-
tation, and she and her husband returned home, leaving the
frozen embryos in Melbourne.76
Several years later, Elsa and Mario were killed in a plane crash
in Chile, leaving "orphaned embryos," a situation neither the Rio-
ses nor the clinic contemplated 7 Once it was discovered that the
couple died intestate with an estate worth more than eight million
dollars, women from around the world volunteered to be surro-
gates to bring the embryos to term in order to make a claim on the
estate. 8
In the summer of 1984, an independent commission of the gov-
ernment of the Australian state of Victoria, where the clinic is
located, decided that the embryos should be destroyed because the
Rioses did not consent to the embryos being brought to term by
another woman and because the embryos had a low chance of sur-
vival given that they were frozen before the perfection of
cryopreservation techniques. 79 A right-to-life outcry ensued, and
70. Id. at 80.
71. Id.
72. Id. at 82 (discussing the unusual circumstances surrounding the couple's quest to
conceive a child).
73. See id.
74. ANDREW KIMBRELL, THE HUMAN BODY SHOP: THE ENGINEERING AND MARKETING
OF LIFE 91 (1993) (detailing the plight of the Rios couple).
75. Id.
76. Id.
77. SILVER, supra note 63, at 82.
78. Id. (discussing the effect of the Daily Telegraph's (London) article "'Orphan' Em-
bryo [sic] Heir to Fortune" on the willingness of women to be surrogate mothers).
79. Id. at 82-83.
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the Victorian parliament voided the commission's recommenda-
tion and prohibited the destruction of the Rios embryos."' At the
same time, a California court, with the agreement of the Victorian
authorities, declared that neither the embryos nor the children
they might become had any claim to the Rios estate."' A California
court awarded the entire estate to the mother of Elsa Rios. In
1987, the Victorian minister of health decreed that the embryos be
transferred to a volunteer's womb (interest had abated because the
embryos had no claim to the Rios estate), but they are still frozen
in liquid nitrogen in Queen Victoria Medical Center in Melbourne
where they may remain indefinitely.83 The Rios case illustrates how
ill-prepared IVF clinics were to address the complicated ethical
and legal issues which could arise as a consequence of long-term
embryo preservation.
2. Ownership of Embryos
a. Davis v. Davis-The Tennessee Supreme Court ad-
dressed the disposition of frozen embryos in Davis v. Davis.s4 Mary
Sue Davis and Junior Lewis Davis married in 1980. Over the next
four years, Mary Sue and Junior tried to achieve a normal preg-
nancy. 5 Mary Sue got pregnant on five separate occasions, but
each time she experienced an ectopic pregnancy in which the em-
bryo implanted in a fallopian tube instead of the uterus.86 Mary Sue
became infertile after having one of her fallopian tubes ligated to
avoid further complication, and IVF became her only hope of get-
ting pregnant.1
7
After six IVF treatments, the embryos failed to implant in Mary
Sue's uterus, and the Davises decided to try cryopreservation, in
which multiple embryos are generated and those not implanted
are frozen in storage for later use. s Nine ova were retrieved, and,
after fertilization, a transfer failed to result in implantation in Mary
Sue's uterus; the remaining embryos stayed frozen. 9 In early 1989,
Junior filed for divorce and sought joint custody of the embryos
while Mary Sue sought sole custody.90 Mary Sue wanted to keep the
80. Id. at 83.
81. Id.
82. KIMBRELL, supra note 74, at 92.
83. SILVER, supra note 63, at 83.
84. 842 S.W.2d 588 (Tenn. 1992).
85. Id. at 591.
86. Id.
87. Id.
88. Id. at 591-92.
89. Id. at 592.
90. See Davis v. Davis, No. E-14496, 1989 WL 140495, at *11 (Tenn. Cir. Ct. Sept. 21,
1989) (determining the disposition of the seven embryos).
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embryos for later use, but Junior did not want any children to be
produced from the embryos. 91 The trial court based its decision on
the perceived desires of the embryos, treating them as children in
a custody dispute.9 The court ruled it was in the best interests of
the embryos for Mary Sue to "be permitted the opportunity to
bring [them] to term through implantation.
The appellate court held that "it would be repugnant and offen-
sive to constitutional principles to order Mary Sue to implant these
fertilized ova against her will. It would be equally repugnant to or-
der Junior to bear the psychological, if not the legal, consequences
of paternity against his will." 94 It remanded the case to vest joint
control of the embryos with Junior and Mary Sue. In her appel-
late brief, Mary Sue indicated that she had remarried, no longer
wanted the embryos to be implanted in her, and requested permis-
sion for them to be donated to an infertile couple, an issue to be
addressed by the Tennessee Supreme Court.
96
The Tennessee Supreme Court affirmed the lower court,
holding that embryos "are not, strictly speaking, either 'persons' or
'property,' but occupy an interim category that entitles them to
special respect because of their potential for human life."9' The
court also held that donation of the embryos to an anonymous
infertile couple was impermissible as it "would rob [Junior]
twice-his procreational autonomy would be defeated and his
relationship with his offspring would be prohibited."9 The court
indicated that its ruling meant that the fertility clinic should follow
its normal procedure for dealing with unused embryos, as long as
that procedure was not in conflict with the court's ruling.9  The
court later stated in its order on a petition to rehear that the
fertility clinic could not donate the surplus embryos to a childless
couple, even though that was its usual procedure.' 0 Instead, it
mentioned the option of donating the embryos for research if




94. Davis v. Davis, No. 180, 1990 WL 130807, at *3 (Tenn. Ct. App. Sept. 13, 1990)
(directing the lower court to award joint custody to junior and Mary Sue).
95. Id.
96. Id. at *1 n.1.
97. Davis v. Davis, 842 S.W.2d 588, 597 (Tenn. 1992).
98. Id. at 604.
99. Id. at 605.
100. Davis v. Davis, No. 34, 1992 WL 341632, at *1 (Tenn. Nov. 23, 1992).
101. Id. at *2.
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alternative was to discard the embryos.10 2 The case was appealed to
the United States Supreme Court, which denied certiorari. 
°
0
Ultimately, Junior was awarded sole custody through further
appeals, removing the requirement to obtain Mary Sue's consent
on the disposition of the embryos, and the embryos were
destroyed. 104
b. Kass v. Kass-In a recent case similar to Davis v. Davis, the
New York Court of Appeals, the state's highest court, ordered a
divorced couple to abide by a signed agreement that prevented the
woman from being implanted with an embryo when her ex-
husband did not want a child. 05 Maureen and Steven Kass disa-
greed about the fate of five frozen embryos remaining in liquid
hydrogen five years after their divorce.'0 6 Maureen wanted the em-
bryos in order to become pregnant, but her ex-husband did not
want to raise a child with her.'0 7 The court relied on an informed
consent agreement signed by the couple before the cryopreserva-
tion procedure.'0s In the informed consent document, the Kasses
agreed that if they no longer wished to initiate a pregnancy, they
would donate the frozen embryos for biological studies and re-
search approved by the clinic's IVF program.109
In Davis, the court stated that if the Davises consented, it would
defer to a disposition suggested by the American Fertility Society's
Ethics Committee calling for donation of the embryos for medical
research." In Kass, the court invoked contract law, in which the
former couple signed an informed consent document choosing to
donate their embryos for research in the event that they could not
make a united decision on the disposition of the embryos."' Both
courts acknowledged the special nature of the embryo in its use-
fulness for medical research as a preferred alternative to
destruction. Both courts recognized a dignity inherent in the em-
bryo that prefers the use of the embryos for implantation, or, if
not, at least for a noble purpose such as medical research. As a re-
sult of the widely publicized situation involving the orphaned
102. Id.
103. Davis v. Davis, No. 34, 1992 WL 341632 (Tenn. Nov. 23, 1992), cert. denied 507 U.S.
911 (1993).
104. Embyyos from Court Battle are Destroyed, Com. APPEAL (Memphis, Tenn.), June 15,
1993, at B3.
105. Kass v. Kass, 696 N.E.2d 174, 181 (N.Y. 1998).
106. Id. at 175.
107. Id.
108. Id. at 182.
109. Id. at 176-77.
110. Davis v. Davis, No. 34, 1992 WL 341632, at * 2 (Tenn. Nov. 23, 1992).
111. Kass, 696 N.E.2d at 176-77.
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embryos in Australia and the proliferation of cryopreservation
techniques, 1VF clinics created informed consent forms addressing
the disposition of frozen embryos in the event of separation, di-
vorce, death, or lack of interest in becoming pregnant.1 12 The
option allowing for donation for medical research purposes shows
the value placed on the continued use of the embryo for a life-
giving purpose even if the embryo itself will not develop into a
human being.
3. Abandoned Embryos-In Great Britain, the government be-
came involved in the disposition of frozen embryos when it passed
a law in 1990 allowing for the destruction of all unclaimed frozen
embryos within five years of the law's effective date, August 1,
1991.113 The law gained worldwide attention in the months before
August 1, 1996, when more than 9000 frozen embryos, which had
been in storage prior to the law's effective date, were subject to
destruction.'1 4 In the months before the deadline, IVF clinics at-
tempted to contact all of the couples who had not indicated what
they wanted to do with their stored embryos.1 1 5 The couples re-
sponding accounted for 6000 of 9000 embryos; of those
responding, forty-seven percent offered them for research, thirty
percent decided to keep them in storage for future use, fifteen
percent donated them to other couples, and only eight percent
agreed to allow the embryos to be destroyed.1 16 The clinics did at-
tempt to locate all of the couples who had frozen embryos in
storage. Unclaimed embryos were deemed abandoned. Conse-
quently, these embryos were to be thawed out, with a drop of water
or alcohol then added, causing the cells to disintegrate."7 Many pro-
life groups protested the government's decision, including a Ro-
man Catholic group of more than 100 Italian women, including
two elderly nuns, who offered to adopt the embryos."' What the
112. See Lauri Gray Eaton, Extra Embryos: What Is Their Future, NORTHSIDE RECORDER
(San Antonio, Tex.),Jan. 4, 2001, at 28 (explaining that most IVF clinics require couples to
sign informed consent forms with options of donating the embryos for scientific research,
donating the embryos to an infertile couple, or discarding the embryos).
113. Fred Barbash, British Frozen Embryos Face Disposal; Thousands of Fertilized Eggs Reach
Legal Deadline for Thawing, WASH. POST, Aug. 1, 1996, at Al (describing opposition to the
British government's plan to dispose of unclaimed frozen embryos).
114. Id.
115. Id.
116. Jeremy Laurance, Plea to Couples to Save 3,300 Embryos from Destruction, TIMES
(London), July 23, 1996, at Home News Section, available at 1996 WL 6508344 (discussing
the efforts by IVF clinics to locate prospective parents of frozen embryos).
117. Id.
118. Philip Willan, Italians in Bid to Save Embryos, TIMES (London), July 27, 1996, at
Overseas News Section, available at 1996 WL 6509260.
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group hoped to do with the embryos is unclear; its primary goal
appeared to be preventing the destruction of the embryos.
There are no federal laws in the United States permitting the
destruction of frozen embryos without the consent of the donors.
Although nearly half of the British couples initially contacted
showed a preference for donating their embryos for research, the
British government chose to destroy the embryos without consent
rather than donate the embryos for research without consent. If
diligent efforts were made to locate the donors accounting for the
3000 unclaimed embryos, the presumption should be that those
embryos were abandoned and could be put to use for research.
The British law, however, requires donor consent to preserve an
embryo longer than five years;1 9 it mandates destruction after a
period corresponding to the age of the female donor. 20 Perhaps
this indicates the British government's disregard for the notion of
the special nature of the embryo, a recognition which allows for
destruction without consent, but also makes research less likely to
be inhibited by Parliament if it does not believe that the embryo is
something special. Such an attitude makes British research involv-
ing embryos far less restricted than such research in the United
States, even to the point where embryos soon will be cloned for
research purposes in Great Britain.'2'
Law and society will continue to wrestle with how to address the
special nature of the embryo. There are those who believe that the
embryo should be treated with all the same rights as a person be-
cause the unique genetic makeup of the embryo is complete at
conception. 22 Adherents of this view object to the intentional de-
struction of embryos as well as research that will result in
destruction. 23 They also object to IVF in general because it results
in surplus embryos, and therefore the most acceptable solution to
them is to donate the extra embryos to infertile couples. 24 This
viewpoint is strongly linked to anti-abortion sentiment, likening
the harvesting of stem cells to abortion because the act of deriving
119. Human Fertilisation and Embryology Act, c. 37, § 14 (1990) (Eng.).
120. Human Fertilisation and Embryology Regulations, §§ 2(1), 3 (1996) (Eng.).
121. Sarah Hall & Tim Radford, Peers Vote to Permit New Research on Embryos, GUARDIAN
(London),Jan. 23, 2001, at 2 (describing the newly enacted British law allowing scientists to
clone embryos and keep them alive for up to fourteen days to extract stem cells).
122. See Carl H. Coleman, Procreative Liberty and Contemporaneous Choice: An Inalienable
Rights Approach to Frozen Embryo Disputes, 84 MINN. . REV. 55, 66 (1999) (discussing the vary-
ing views of the moral status of human embryos).
123. Id. at 66-67.
124. Id. at 67.
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the HPSCs destroys the live embryo. 12 5 Proponents of this view
staunchly equate federal funding of stem cell research with com-
plicity in the taking of human life.126 On the other side, there are
those who believe that embryos do not have a special moral status
and should be viewed merely as property.127 This view allows for the
destruction of embryos for any reason, including research.
12 8
Adherents of the middle position, that the embryo is something
other than living or dead, do not object to the destruction of un-
wanted embryos or to their use for scientific and medical
research. 29 Indeed, the American Medical Association has stated
that frozen embryos may be donated, but not sold, to infertile
couples or researchers, or may be allowed to thaw and deterio-
rate.130 Acknowledging that the embryo is alive, but that its special
nature comes from the recombinant DNA within it, may be one
step toward appeasing stem cell research opponents.13 ' This argu-
ment rests on the fact that DNA is the personifying feature of a
100-cell blastocyst, rather than the egg wall, cytoplasm, and mito-
chondria, which are destroyed in stem cell derivation. 132 HPSCs
derived from harvested embryos are directed to form cell lines,
each of which contains, in dormant form, the full component of
embryonic DNA. 133 The DNA has a higher probability of existing
for many years than the DNA of a frozen embryo, which will most
125. See Richard M. Doerflinger, The Ethics of Funding Embryonic Stem Cell Research: A
Catholic Viewpoint, 9 KENNEDY INST. ETHICSJ. 137, 141 (1999).
126. See id. at 145-46.
127. Coleman, supra note 122, at 67.
128. See R. Alta Charo, The Hunting of the Snark: The Moral Status of Embryos, Right-to-
Lifers, and Third World Women, 6 STAN. L. & POL'Y REv. 11, 16 (1995) (asking if the potential
to be born entitles an entity to be treated as if it already were born (citing Michael Tooley,
In Defense of Abortion and Infanticide, in WHAT IS A PERSON? 83-114 (Michael F. Goodman
ed., 1988) (characterizing the problem of labeling the destruction of potential as wrong
when the being with the potential to be born has no ability to perceive it is being
wronged))).
129. Coleman, supra note 122, at 69 n.66 (explaining that most supporters of this view
favor limiting embryo research to the first fourteen days of development before the
.primitive streak," the precursor of the nervous system, develops) (citingJohn A. Robertson,
Embryos, Families, and Procreative Liberty: The Legal Structure of the New Reproduction, 59 S. CAL.
L. REv. 939,983-84 (1986)).
130. See Heidi Forster, Recent Development, The Legal and Ethical Debate Surrounding the
Storage and Destruction of Frozen Human Embryos: A Reaction to the Mass Disposal in Britain and
the Lack of Law in the United States, 76 WASH. U. L.Q. 759, 766 (1998) (citing COUNCIL ON
ETHICAL AND JUDICIAL AFFAIRS, AMERICAN MED. ASS'N, CODE OF MEDICAL ETHICS: CUR-
RENT OPINIONS WITH ANNOTATIONS § E-2.141 (1994)).
131. Glenn McGee & Arthur Caplan, The Ethics and Politics of Small Sacrifices in Stem Cell
Research, 9 KENNEDY INST. ETHICSJ. 151, 154 (1999).
132. Id. at 155.
133. Id.
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likely be discarded by an IVF clinic.13 1 In this sense, the life within
the embryonic DNA lives on in the HPSCs derived from the embryo.
III. CURRENT STATE OF FEDERAL LAW
A. Federal Law on Fetal Tissue Research
The United States Supreme Court decision in Roe v. Wade 5 in
1973 forever politicized the abortion debate. 36 The Court held in
Roe that, absent a compelling state interest in protecting her
health, a woman has the right to choose whether to terminate her
pregnancy based on a fundamental privacy right.137 Justice Black-
mun adopted a trimester analysis, where the state has no interest
in the first trimester but has a compelling interest in the woman's
health in the second trimester because abortion becomes much
more dangerous after the first twelve weeks of pregnancy.3 8 The
state acquires an interest in protecting the life of the fetus either
when it reaches the third trimester or when it reaches the point of
viability.
39
In the wake of Roe, Congress grew concerned about the possibil-
ity of the exploitation of fetuses from elective first- and second-
trimester abortions and enacted a moratorium on federal funding
of fetal tissue research in 1974.'14 The National Commission for the
Protection of Human Subjects of Biomedical and Behavioral Re-
search was given a congressional mandate to recommend a
134. Id.
135. 410 U.S. 113 (1973).
136. See generally BARBARA H. CRAIG & DAVID M. O'BRIEN, ABORTION & AMERICAN
POLITICS (1993) (discussing how the abortion controversy has played out in the operation
of American government and politics); CYNTHIA GORNEY, ARTICLES OF FAITH: A FRONTLINE
HISTORY OF THE ABORTION WARS (1998) (presenting a political and social narrative of the
significant years in the abortion conflict through interviews with people on both sides of the
issue); JAMES RISEN & JUDY THOMAS, WRATH OF ANGELS: THE AMERICAN ABORTION WAR
(1998) (tracing the evolution of the anti-abortion movement and its role in the creation of
the religious right); LAURENCE H. TRIBE, ABORTION: THE CLASH OF ABSOLUTES (1990)
(attempting to explain and justify the constitutional theory of reproductive freedom).
137. Roe, 410 U.S. at 163-65.
138. Id. at 155-65.
139. Id. at 165. In 1992, the United States Supreme Court affirmed, but weakened, the
right to an abortion. See Planned Parenthood of S.E. Penn. v. Casey, 505 U.S. 833, 846-51,
869 (1992) (upholding restrictive Pennsylvania abortion legislation, except for spousal-
notice provisions, under the due process clause of the Fourteenth Amendment).
140. See National Research Service Award Act, 42 U.S.C. § 289(e)-1 (1974).
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framework for federal regulations governing fetal tissue research.141
The regulations arising from those recommendations provided for
the establishment of ethical advisory boards (EABs) able to handle
all the complex issues related to fetal tissue research including le-
gal, ethical, and medical issues. 142 The EABs were supposed to
advise the Secretary of Health and Human Services (HHS) regard-
ing issues raised by individual research proposals. 3 The first EAB
did not convene until 1978, however, at which time research on
fetal tissue from nonviable fetuses obtained from elective abortions
commenced under strict guidelines. This research continued until
March 1988 when the NIH banned all fetal tissue research involv-
ing tissue obtained from electively aborted fetuses.' 44 This measure
ostensibly was taken out of fear that the laudable goals of fetal tis-
sue research might destigmatize the abortion procedure and make
it more acceptable in society.
Acknowledging the importance of fetal tissue research, Presi-
dent George H.W. Bush issued an executive order in 1992 calling
for the establishment of a national fetal tissue bank without lifting
the moratorium on federal funding of fetal tissue research involv-
ing electively aborted fetuses.' 45 The fetal tissue in the bank was to
be obtained "exclusively from ectopic pregnancies and spontane-
ous abortions." 46 Tissue from the bank was to be made available to
"physicians and hospitals interested in using the tissue from the
bank to further specific medical objectives." 47 The fetal tissue bank
still did not permit fetal tissue obtained from elective abortions to
be included in the bank, even though tissue from aborted fetuses
is most useful in fetal tissue research because it is typically not




Finally, in 1993, President Bill Clinton ordered the repeal of the
moratorium on fetal tissue research involving electively aborted
fetuses because it has "significantly hampered the development of
possible treatments for individuals afflicted with serious diseases
141. See National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research: Research on the Fetus, Report and Recommendations, 40 Fed. Reg.
33,350 (1975) (codified at 45 C.F.R. §§ 46.101-301).
142. 45 C.F.R. § 46.204(a) (1987).
143. 45 C.F.R. § 46.204(b) (1987).
144. Kolata, supra note 4, at F1 (discussing the HHS assistant secretary's ban of federal
funding of fetal tissue research).
145. Exec. Order No. 12,806, 57 Fed. Reg. 21,589 (May 19, 1992) (establishing a na-
tional fetal tissue bank).
146. Id.
147. Id.
148. Fackelmann, supra note 11, at 6.
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and disorders, such as Parkinson's disease, Alzheimer's disease,
diabetes, and leukemia.", 49 The law currently allows for the use of
human fetal tissue from elective abortions if the donor gives con-
sent and if there is no alteration of the abortion procedure in
order to facilitate obtaining the tissue.150 Congress passed another
law making it "unlawful for any person to knowingly acquire, re-
ceive, or otherwise transfer any human fetal tissue for valuable
consideration if the transfer affects interstate commerce."' 5' This
law was designed to address possible trafficking in fetal tissue and
may become more strictly enforced. In the last six years, the NIH
has awarded approximately $110 million in grants for fetal tissue
research, largely for the study of diabetes, digestive, kidney, and
nerve diseases. 152 Federally funded fetal tissue researchers are still
struggling to make up for the nearly five years they lost when fed-
erally funded fetal tissue research involving electively aborted
fetuses was banned.
B. Federal Law on Stem Cell Research
In 1980, Congress passed a law allowing federal funding of em-
bryological research following a favorable review by the HHS EAB
regarding ethical issues for a specific project.55 The EAB con-
cluded IVF research was acceptable, but because the NIH did not
initiate any projects involving embryological research, no research
was funded. 154 In 1993, Congress repealed the regulation so that
embryological research could receive federal funding unless an
EAB made a contrary finding.
55
The NIH formed the Human Embryo Research Panel to prom-
ulgate guidelines for reviewing grant requests, and the panel
recommended proceeding with embryological research on Sep-
tember 27, 1994.156 The NIH Advisory Committee to the Director
149. Memorandum for the Secretary of Health and Human Services, Federal Funding
of Fetal Tissue Transplantation Research, 58 Fed. Reg. 7,457, 7,457 (Jan. 22, 1993).
150. 42 U.S.C. § 289g-l (b) (2) (1994).
151. 42 U.S.C. § 289g-2 (a).
152. Murphy, supra note 50, at Al (outlining the positions of proponents and oppo-
nents of fetal tissue research).
153. See Health and Human Services Policy for Protection of Human Subjects Research,
59 Fed. Reg. 28,276, 28,276 (June 1, 1994) (to be codified at 45 C.F.R. pt. 46).
154. Id.
155. See id.
156. Laurie McGinley, U.S. Panel Backs Human-Embryo Studies, ASIAN WALL ST. J., Sept.
29, 1994, at 26.
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voted to accept the panel's report, but on December 2, 1994,
President Clinton directed the NIH to forgo funding any projects
involving the creation of embryos solely for research.5 7 Embryo-
logical research was further hampered by the budget compromise
in 1996 that prohibited the use of federal funds for the creation of
human research embryos or embryo research in which the embryo
is destroyed, such as the derivation of HPSCs
5 8
On January 15, 1999, HHS issued a legal opinion finding that
the statutory prohibition of the use of federal funds for human
embryological research would not apply to research using HPSCs
because HPSCs do not constitute an embryo. 15" According to Dr.
Harold Varmus, the former NIH Director, research on HPSCs is
different from research on embryos because HPSCs do not have
the capacity to become human beings.' 60 On August 25, 2000, the
NIH authorized federal funding for research involving HPSCs in a
narrow sense.' 6' Studies using HPSCs derived from human embryos
may be conducted with NIH funds only if the HPSCs were derived
without federal funds "from human embryos that were created for
the purposes of fertility treatment and were in excess of the clinical
need of the individuals seeking such treatment." 62 Although NIH
researchers are not allowed to derive HPSCs, federal funds may be
used to support research deriving cells from fetal tissue, a curious
anomaly.
16
In April 2001, Sen. Arlen Specter (R-Pa.) introduced the Stem
Cell Research Act of 2001 in order to provide more freedom for
federally funded researchers to work with HPSCs. Sen. Specter ex-
plained the purpose of the Stem Cell Research Act of 2001:
[W] e have a duty to accelerate medical research by allowing
researchers to utilize Federal funds to derive their own stem
cells. Human embryonic stem cell research holds such poten-
tial for millions of Americans who are sick and in pain that we
believe it is wrong for us to prevent or delay our world-class
scientists from building on the progress that has been made.
Our legislation creates one narrow and specific source for
157. John Schwartz & Ann Devroy, Clinton to Ban U.S. Funds for Some Embryo Studies,
WASH. POST, Dec. 3, 1994, at Al.
158. See Balanced Budget Downpayment Act of 1996, Pub. L. No. 104-99, § 128, 110
Stat. 26, 34.
159. 146 CONG. REc. S150, 150 (daily ed. Jan. 31, 2000) (statement of Sen. Specter)
[hereinafter SPECTER STATEMENT].
160. Id.
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Federal researchers to obtain embryos for use in stem cell re-
search: embryos which would otherwise be discarded from in-
vitro fertilization clinics, with the expressed consent of the
donating families. In addition, a provision is included which
requires that all Federally-funded research must adhere to
strict procedural and ethical guidelines to ensure that such
research is conducted in an ethical, sound manner. It is im-
portant to note that as it stands today, embryonic stem cell
research in the private sector is not subject to Federal moni-
toring or ethical requirements. 161
The bill would grant permanent authority to the HHS Secretary
to fund research on human embryos solely for the purpose of gen-
erating stem cells. 65 Only embryos discarded and donated by IVF
clinics with the informed consent of the donors would be permit-
ted. 6 6 Sen. Specter acknowledged in a news conference that the bill
is going to be controversial and noted that the 'Jury is still out on
how it will come out."' 67 The bill has been referred to the Senate
Health, Education, Labor, and Pensions Committee for review.5
CONCLUSION
In the course of the debate involving abortion (fetal tissue re-
search), and the "killing" of potential human life (stem cell
research), an implicit hierarchy developed affording the fetus the
most legal protection, followed by the human embryo, and then
the HPSC. Somewhere in this chain lie fetal parts, ostensibly
granted less protection because they do not constitute a whole be-
ing, and because they do not have the potential to become alive.
Lately, though, the paradigm has shifted. There are actually fewer
restrictions on fetal tissue research than on research involving
HPSCs. Why should there be more protection for discarded hu-
man embryos and the stem cells within them? Discarded embryos
result from a decision by the donors not to implant the embryos
for pregnancy. Recognizing their potential to become human be-
ings belies the fact that these discarded embryos were abandoned
164. 147 CONG. REc. S3553, 3553 (daily ed. Apr. 5, 2001) (statement of Sen. Specter).
165. S. 723, 107th Cong. § 1(2001).
166. Id.
167. Stem Cell Bill Hits Senate Floor, BLUE SHEET, Apr. 11, 2001, available at 2001 WL
7811152.
168. S. 723, 107th Cong. § 1 (2001), available at http://thomas.loc.gov.
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by their donors. A true supporter of the sanctity of human life
should see the invaluable contributions that HPSCs can make in
improving the lives of those already living.
Some scientists fear that the new pro-life Republican administra-
tion may stop federally funded HPSC research." 9 Indeed, President
George W. Bush has stated his opposition to embryonic stem cell
research, and HHS Secretary Tommy Thompson successfully
evaded the issue in his Senate confirmation hearings. 7° Those who
support the pro-life position should want to see HPSCs put to use
to improve the lives of those living in agony. Yet, the vehement
opposition once leveled against the use of fetal tissue now seems
directed against stem cell research. 7'
Those opposed to stem cell research may be persuaded to
change their minds if further studies demonstrate the promise of
stem cells in treating virulent diseases. The best way to do that is to
allow federally funded research to proceed. Even staunch pro-life
Sen. Gordon Smith (R-Or.), whose family has been affected by
169. See Sandra Blakeslee, In Early Experiments, Cells Repair Damaged Brains, N.Y. TIMES,
Nov. 7, 2000, at F1 (discussing the promise of stem cell research); see also Michael J. Fox,
Editorial, A Crucial Election for Medical Research, N.Y. TIMES, Nov. 1, 2000, at A33 (referring to
comments made by campaign aides to then Governor George W. Bush that his administra-
tion would ban federal funding for stem cell research). Numerous groups have lobbied
President Bush to support stem cell research, including eighty Nobel laureates who urged
him not to block federal funding for the research. Rick Weiss, Nobel Laureates Back Stem Cell
Research, WASH. POST, Feb. 22, 2001, atA2.
170. Sheryl Gay Stolberg, Stem Cell Research Advocates in Limbo, N.Y. TIMES,Jan. 20, 2001,
at A17 (showing President Bush's opposition to federal funding of "experimentation on
embryonic stem cells that require live human embryos to be discarded or destroyed"). Al-
though HHS Secretary Thompson supported privately funded stem cell research while
governor of Wisconsin, his position on federal funding remains unknown. See id. President
Bush directed Thompson to review the HHS stem cell research policy, and Thompson has
promised to make a recommendation by summer on whether federally funded stem cell
research will proceed. Marlene Cimons, Stem Cell Study Decision Due by Summer, L.A. TIMES,
Mar. 1, 2001, at A16. In April, HHS canceled the inaugural meeting of the NIH committee
that was to review the first applications from scientists seeking federal funds for HPSC re-
search. Rick Weiss, Bush Administration Order Halts Stem Cell Meeting, WASH. POST, Apr. 21,
2001, at A2. The meeting of the newly formed Human Pluripotent Stem Cell Review Group,
which includes scientific, ethical, and theological experts, has not been rescheduled. Id.
The NIH, which was recently offered a 13.5% increase in its budget for the upcoming fiscal
year by the Bush administration, did not fight the cancellation of the committee meeting.
Id.
171. 145 CONG. REc. E1696, 1697 (July 30, 1999) (quoting Rep. Bob Schaffer (R-
Colo.)) ("The logic of this practice is not unlike that of the Third Reich, where torture was
rationalized for medical research. It is something no civilized nation should condone, much
less fund with tax dollars of conscientious, disapproving Americans."); see, e.g., Bill Tam-
meus, Editorial, When Science Outruns Common Knowledge, RAN. CITY STAR, Sept. 3, 2000, at
Bll (referring to Sen. Sam Brownback (R-Kan.), who described stem cell research as
"illegal, immoral and unnecessary").
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Parkinson's disease, supports this expansion of embryonic stem
cell research.'72
Another effective means of gathering support for stem cell re-
search involves further using celebrities to raise awareness.173
Christopher Reeve, the quadriplegic actor and director, actively
campaigns for using HPSCs to repair spinal cord damage. 74 Actor
Michael J. Fox has testified before the United States Senate on be-
half of Parkinson's disease research. 7 5 This type of attention could
motivate the public to become more involved and lobby Congress
for government funding for research. 7 6
Ronald Green, Director of the Dartmouth College Ethics Insti-
tute,177 has suggested policy determinations involving HPSCs
proceed on the theory of "public reason.",7 8 "Public reason" entails
using arguments that appeal to widely shared human values and
avoid appeal to religious or moral claims that are unsustainable on
common sense or evidentiary grounds.179 Such public values in-
clude access to publicly funded health-related research.'80 Green
acknowledges the right to discuss objections to such research, but
172. Robin Toner, The Abortion Debate, Stuck in Time, N.Y. TIMES,Jan. 21, 2001, § 4, at 1
(quoting Sen. Smith as saying "'My pro-life beliefs guide me to make life better for the liv-
ing as well, to relieve suffering where there is pain, and to find cures for deadly diseases
wherever possible.'"). Other pro-life supporters of HPSC research include Sen. Strom
Thurmond (R-S.C.) and former Sen. Connie Mack (R-Fla.). Aaron Zitner & Marlene Ci-
mons, Nominee Crosses Stem CellDivide, L.A. TiMEs,Jan. 18, 2001, at A13.
173. Mark Ebner & Lisa Derrick, Star Sickness: Celebrities Speaking Out About Their Afflic-
tions Can Raise Awareness and Money, SALON.COM, Nov. 29, 1999, at http://www.salon.com/
health/feature/1999/11/29/celebdisease/index.html (on file with the University of Michi-
gan Journal of Law Reform) (discussing how celebrities, through congressional testimony and
public awareness campaigns, have put familiar faces on diseases that otherwise might have
hovered below the high-profile funding radar).
174. Good Morning America: Christopher and Dana Reeve Discuss Fundraising and Research
on Behalf of Spinal Cord Injuries (ABC television broadcast, Mar. 19, 2001) (announcing the
formation of a coalition of medical researchers and drug companies to advance stem cell
research).
175. Ebner & Derrick, supra note 173 (quoting MichaelJ. Fox as saying, "'What celeb-
rity has given me is the opportunity to raise the visibility of Parkinson's disease and focus
attention on the desperate need for more research dollars.'").
176. See id.
177. The Dartmouth College Ethics Institute recently sponsored a symposium on the
scientific and ethical issues surrounding stem cell research. See Realvideo Presentations of... A
Student Science Court: The Future of Stem Cell Research, at http://www.dartmouth.edu/
-ethics/start.htm (Jan. 29, 2000) (on file with the University of Michigan Journal of
Law Reform).
178. Ronald M. Green, StoppingEmbryo Research, 9 HEALTH MATRIX:J. L.-MED. 235, 248
(1999) (citing John Rawls, The Idea of Public Reason, in POLITICAL LIBERALISM 212 (1993)






argues that religious and ethical claims that cannot withstand ob-
jectively reasoned analysis should not play a role in these
discussions.""
Unfortunately, this issue is complicated by the special nature of
the embryo. The frozen embryo, in particular, exists on a plane
distinct from something that is clearly alive or clearly dead. It may
seem difficult to reconcile consciously destroying something that
was deliberately created. Perhaps that is why the United States
should follow the lead of Great Britain, which became the first na-
tion to legalize the cloning of human embryos for research.
8 2
Congress has forbidden federal funding for the cloning of human
embryos specifically for research purposes, 3 but these would be
embryos created not for reproduction but specifically to derive
HPSCs. Creating embryos knowing that they are going to be used
to derive HPSCs may reduce the intensity of the special nature of
the embryo. HPSCs do not have the capacity to become human
beings, so fears of a Brave New World scenario are unfounded.
4
Although the ideal situation pictures NIH researchers cloning
embryos and then deriving stem cells, realistically, small steps must
be taken to achieve great strides. The first and most important step
involves passing the Stem Cell Research Act of 2001 to allow
federally funded researchers the ability to conduct scientific
research absent arbitrary restrictions.1 8 5 The Act would permit
181. See id. at 248-51 (citing Alex Mauron, The Human Embryo and the Relativity of Bio-
logical Individuality, in CONCEIVING THE EMBRYO: ETHICS, LAW AND PRACTICE IN HUMAN
EMBRYOLOGY 55, 66-67 (Donald Evans, ed., 1986)). Using Swiss philosopher Alex Mauron's
discussion of the ethical challenges surrounding those holding idiosyncratic moral beliefs,
Green argues it would violate public ethics in a pluralistic democracy for such people to
impose their non-publicly sustainable views on others and would corrupt the integrity of an
independently established scientific review process.
182. The House of Commons approved the measure by a vote of 366 to 174, amending
the Human Fertilisation and Embryology Act to allow human embryo cloning for stem cell
research. British Bill on Human Embryo Clones Gains, N.Y. TIMES, Dec. 20, 2000, at A20. The
House of Lords later approved the measure 212 to 92. Hall & Radford, supra note 121, at 2.
183. Consolidated Appropriations Act, 2001, Pub. L. No. 106-554, 114 Stat. 2763,
2763A-71 (2000). Federal funding for this activity has been forbidden for more than five
years. Consolidated Appropriations Act, 2000, Pub. L. No. 106-113, 113 Stat. 1501, 1501A-
275 (1999); Omnibus Consolidated and Emergency Supplemental Appropriations Act,
1999, Pub. L. No. 105-277, 112 Stat. 2681, 2681-386 (1998); Departments of Labor, Health
and Human Services, and Related Agencies Appropriations Act, 1998, Pub. L. No. 105-78,
111 Stat. 1467, 1517 (1997); Omnibus Consolidated Appropriations Act, 1997, Pub. L. No.
104-208, 110 Stat. 3009, 3009-270 (1996).
184. See generally ALDOUS HUXLEY, BRAVE NEW WORLD (Perennial Classics 1998) (1932)
(envisioning a world in which the population is divided into five castes, governed by supply
and demand, and the number of people is controlled by adjusting test tube births and mul-
tiplying embryos that will be born into the lower castes).
185. In January 2000, Sen. Specter and Sen. Tom Harkin (D-Iowa) introduced the Stem
Cell Research Act of 2000, identical to the Stem Cell Research Act of 2001, but the bill never
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these researchers to actually work with embryos discarded from
IVF clinics and to derive the HPSCs on their own without relying
on private researchers to do it for them.
Allowing federally funded researchers this level of autonomy will
greatly accelerate advances in the study of diseases and expedite
the development of necessary treatments. Enough time has been
wasted leveraging for political gain in the debates surrounding fe-
tal tissue research and stem cell research. It is time for the political
semantics to end and for life-saving research to begin unencum-
bered.
left the Senate Health, Education, Labor, and Pensions Committee for a debate on the Senate
floor. S. 2015, 106th Cong. § 2 (2000), available at http://thomas.loc.gov. Senate Majority
Leader Trent Lott (R-Miss.) indicated his willingness to "make sure it will not fall through[,]"
but there was no further activity on the Act. 146 CONG. Rc. S9448 (Sept. 28, 2000) (statement
of Sen. Lott). Rep. Carolyn Maloney (D-N.Y.) and Rep. Connie Morella (R-Md.) recently
introduced a resolution in the 107th Congress, supporting federal funding of pluripotent
stem cell research, but the resolution does not call for allowing federally funded researchers
to derive their own stem cells. H.R. Con. Res. 17, 107th Cong. (2001), available at
http://thomas.loc.gov.
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